1 January 2023 false No description of principal activity Taxfiler 2023.15 12968151business:PrivateLimitedCompanyLtd2023-01-012023-12-31 129681512022-12-31 129681512023-01-012023-12-31 12968151business:AuditExemptWithAccountantsReport2023-01-012023-12-31 12968151business:FilletedAccounts2023-01-012023-12-31 129681512023-12-31 12968151business:Director12023-01-012023-12-31 12968151business:RegisteredOffice2023-01-012023-12-31 129681512022-12-31 12968151core:WithinOneYear2023-12-31 12968151core:WithinOneYear2022-12-31 12968151core:AfterOneYear2023-12-31 12968151core:AfterOneYear2022-12-31 12968151core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 12968151core:ShareCapitalcore:PreviouslyStatedAmount2022-12-31 12968151core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 12968151core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-12-31 12968151core:PreviouslyStatedAmount2023-12-31 12968151core:PreviouslyStatedAmount2022-12-31 12968151business:SmallEntities2023-01-012023-12-31 12968151countries:EnglandWales2023-01-012023-12-31 12968151core:PlantMachinery2023-01-012023-12-31 12968151core:ComputerEquipment2023-01-012023-12-31 12968151core:PlantMachinery2022-12-31 12968151core:ComputerEquipment2022-12-31 12968151core:PlantMachinery2023-12-31 12968151core:ComputerEquipment2023-12-31 12968151business:OrdinaryShareClass12023-01-012023-12-31 12968151business:OrdinaryShareClass12021-11-012022-12-31 129681512021-11-012022-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 12968151 (England and Wales)
COMPASS PHARMA LTD Unaudited accounts for the year ended 31 December 2023
COMPASS PHARMA LTD Unaudited accounts Contents
Page
- 2 -
COMPASS PHARMA LTD Company Information for the year ended 31 December 2023
Director
Ms Tracy Pettitt
Company Number
12968151 (England and Wales)
Registered Office
UNIT 51 ROMSEY INDUSTRIAL ESTATE GREATBRIDGE ROAD ROMSEY HAMPSHIRE SO51 0DR ENGLAND
Accountants
Cone Accounting Limited 124 City Road London EC1V 2NX
- 3 -
COMPASS PHARMA LTD Statement of financial position as at 31 December 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
622 
445 
Current assets
Inventories
16,389 
- 
Debtors
14,505 
1,882 
Cash at bank and in hand
25,144 
24,649 
56,038 
26,531 
Creditors: amounts falling due within one year
(37,463)
(52,891)
Net current assets/(liabilities)
18,575 
(26,360)
Total assets less current liabilities
19,197 
(25,915)
Creditors: amounts falling due after more than one year
(250,642)
(90,000)
Net liabilities
(231,445)
(115,915)
Capital and reserves
Called up share capital
84 
84 
Profit and loss account
(231,529)
(115,999)
Shareholders' funds
(231,445)
(115,915)
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 29 February 2024 and were signed on its behalf by
Ms Tracy Pettitt Director Company Registration No. 12968151
- 4 -
COMPASS PHARMA LTD Notes to the Accounts for the year ended 31 December 2023
1
Statutory information
COMPASS PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 12968151. The registered office is UNIT 51 ROMSEY INDUSTRIAL ESTATE, GREATBRIDGE ROAD, ROMSEY, HAMPSHIRE, SO51 0DR, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
Straight Line Method - 20%
Computer equipment
Straight Line Method - 33.33%
4
Tangible fixed assets
Plant & machinery 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 January 2023
- 
499 
499 
Additions
403 
- 
403 
At 31 December 2023
403 
499 
902 
Depreciation
At 1 January 2023
- 
54 
54 
Charge for the year
60 
166 
226 
At 31 December 2023
60 
220 
280 
Net book value
At 31 December 2023
343 
279 
622 
At 31 December 2022
- 
445 
445 
- 5 -
COMPASS PHARMA LTD Notes to the Accounts for the year ended 31 December 2023
5
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
VAT
5,911 
1,798 
Trade debtors
1,873 
- 
Accrued income and prepayments
6,721 
- 
Other debtors
- 
84 
14,505 
1,882 
6
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Trade creditors
32,938 
251 
Taxes and social security
1,991 
1,900 
Other creditors
600 
139 
Loans from directors
1,374 
50,601 
Accruals
560 
- 
37,463 
52,891 
7
Creditors: amounts falling due after more than one year
2023 
2022 
£ 
£ 
Other creditors
250,642 
90,000 
8
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
84 Ordinary shares of £1 each
84 
84 
9
Average number of employees
During the year the average number of employees was 2 (2022: 2).
- 6 -